Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$824M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$459M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
| 4 |
Warner Bros
WBD
|
+$287M |
| 5 |
Tesla
TSLA
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.88B |
| 2 |
AT&T
T
|
+$530M |
| 3 |
Meta Platforms (Facebook)
META
|
+$481M |
| 4 |
Workday
WDAY
|
+$462M |
| 5 |
Apple
AAPL
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.22% |
| 2 | Technology | 1.79% |
| 3 | Consumer Discretionary | 1.52% |
| 4 | Communication Services | 1.04% |
| 5 | Financials | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FST
10501
PUT
DELISTED
FAST Acquisition Corp.
FST
| $205K | ﹤0.01% |
+20,200
| New | +$204K |
|
10502
ALX Oncology
ALXO
$277M
| $204K | ﹤0.01% |
25,193
-30,219
| -55% | -$329K |
|
10503
CALL
American Superconductor
AMSC
$1.38B
| $204K | ﹤0.01% |
39,300
-11,200
| -22% | -$64.9K |
|
|
ASA
10504
CALL
ASA Gold and Precious Metals
ASA
$1.19B
| $204K | ﹤0.01% |
13,900
-10,000
| -42% | -$192K |
|
10505
CALL
Central Pacific Financial
CPF
$974M
| $204K | ﹤0.01% |
9,500
-20,500
| -68% | -$497K |
|
10506
PUT
iShares MSCI Indonesia ETF
EIDO
$491M
| $204K | ﹤0.01% |
9,100
-100
| -1% | -$2.41K |
|
|
GOCO
10507
DELISTED
GoHealth
GOCO
| $204K | ﹤0.01% |
22,742
+6,657
| +41% | +$77.4K |
|
10508
Nuveen ESG US Aggregate Bond ETF
NUBD
$489M
| $204K | ﹤0.01% |
+8,905
| New | +$206K |
|
10509
Global X NASDAQ 100 Risk Managed Income ETF
QRMI
$14.4M
| $204K | ﹤0.01% |
+10,481
| New | +$215K |
|
10510
PUT
Roivant Sciences
ROIV
$25.1B
| $204K | ﹤0.01% |
50,100
+15,500
| +45% | +$61.5K |
|
|
WKEY
10511
PUT
WISeKey
WKEY
$76.4M
| $204K | ﹤0.01% |
32,760
+14,460
| +79% | +$122K |
|
|
XDJL
10512
DELISTED
Innovator US Equity Accelerated ETF July
XDJL
| $204K | ﹤0.01% |
+9,121
| New | +$225K |
|
10513
Astrana Health
ASTH
$1.88B
| $204K | ﹤0.01% |
5,287
-5,818
| -52% | -$221K |
|
|
SMC
10514
PUT
Summit Midstream
SMC
$470M
| $204K | ﹤0.01% |
+16,000
| New | +$279K |
|
|
ALBO
10515
DELISTED
Albireo Pharma Inc
ALBO
| $204K | ﹤0.01% |
10,294
-13,722
| -57% | -$362K |
|
|
PAK
10516
DELISTED
Global X MSCI Pakistan ETF
PAK
| $204K | ﹤0.01% |
+11,341
| New | +$233K |
|
|
ALE
10517
DELISTED
Allete
ALE
| $203K | ﹤0.01% |
3,454
-2,699
| -44% | -$165K |
|
10518
Angi Inc
ANGI
$204M
| $203K | ﹤0.01% |
4,423
-559
| -11% | -$27.4K |
|
10519
PUT
B2Gold
BTG
$7.48B
| $203K | ﹤0.01% |
60,000
-19,800
| -25% | -$82.7K |
|
10520
FT Vest US Equity Deep Buffer ETF November
DNOV
$403M
| $203K | ﹤0.01% |
+6,279
| New | +$208K |
|
10521
PUT
Fortis
FTS
$27.9B
| $203K | ﹤0.01% |
4,300
-16,200
| -79% | -$794K |
|
10522
CALL
Hydrofarm Holdings
HYFM
$4.04M
| $203K | ﹤0.01% |
5,820
-8,190
| -58% | -$666K |
|
10523
nLIGHT
LASR
$2.48B
| $203K | ﹤0.01% |
19,909
-2,331
| -10% | -$30.1K |
|
10524
PUT
Lindblad Expeditions
LIND
$1.94B
| $203K | ﹤0.01% |
25,000
+10,900
| +77% | +$142K |
|
10525
ALPS REIT Dividend Dogs ETF
RDOG
$11.3M
| $203K | ﹤0.01% |
4,746
-24,119
| -84% | -$1.12M |
|
Similar funds
Jeff Yass's Q2 2022 Portfolio in Review
As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
- Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
- Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
- Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
- Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
- Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
- Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.
Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.